Our discussion with Dr. Catherine Zahn, President & CEO of Centre for Addiction and Mental Health, on career drivers, leadership, and the diversity challenges that continue to face us today.
Our discussion with Alayne Metrick – President, St. Michael’s Hospital Foundation on leadership, diversity, team drivers and advice to the next generation.
Despite uncertainties in other sections of the US healthcare industry, those in the business of life science tools and services are riding high.
The president of Bayer Brazil shares his views on how to keep a workforce innovative, socially aware and ahead of the competition.
In what is China’s biggest-yet foreign acquisition, state-owned ChemChina is set to acquire Swiss agribusiness giant Syngenta.
Growing demand from an aging, middle-class population is fuelling world-class innovation in China’s pharmaceutical sector.
A new survey from PwC looks at board composition, with a focus on the number of women on boards in nine key industries in the US.
Consolidation continues in the pharmaceutical sector, with Johnson & Johnson set to scoop up Switzerland’s Actelion in the biggest European drugs takeover in 13 years.
How can organisations thrive in a complex world of risk?